MILITARY

Adhoc Bioversys Ag Bioversys Announces First Patient First Visit in Phase 2B Riv Care Trial of Bv100

MILITARY signal, reported in FR, from finanznachrichten.de, with neutral sentiment. Locations: France, Switzerland.

Sourcesfinanznachrichten.de
Event Time29 Oct 2026, 6:30 AM GMT
CountryFR
SentimentNeutral / Tone -1.88

What This Signal Means

This page turns one GDELT event record into a readable WorldEchoNews signal. The signal is categorized as MILITARY for FR, with neutral sentiment and a tone score of -1.88. 1 distinct reporting source linked to this event.

Tone Reading

The tone score is used as a quick language-intensity indicator. Scores below -5 are treated as negative, scores above 5 are treated as positive, and values between -5 and 5 are treated as neutral. This signal has a moderate neutral reading.

Reporting Sources

These source names were attached to matching GDELT mentions for this event.

finanznachrichten.de
People: Marc Gitzinger, David Paterson, Glenn E Dale
Organizations: University Of Lille, Yong Loo Lin School Of Medicine, National Centre For Infectious Diseases, Head Of Clinical Research
Locations: France, Switzerland
View original source

Activity in FR (last 24 hours)

130signals recorded
-2.97average tone
42strongly negative

Counted across every source WorldEchoNews processed in the window, not just this story.

Other signals from FR